Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck mectizan Donation Program — People Reached Annually for River Blindness & LF (millions)
Merck Impact Report
Latest, FY2025
265.80
Period ended Dec 31, 2025
Change on a year earlier
-9.0%
292.00 in FY2024
History
8 years
Since FY2018
Sources
1
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Mectizan Donation Program — People Reached Annually for River Blindness & LF (millions) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 265.80 | -9.0% | – |
| FY2024 | Dec 31, 2024 | 292.00 | -24.2% | – |
| FY2023 | Dec 31, 2023 | 385.00 | +7.3% | – |
| FY2022 | Dec 31, 2022 | 358.90 | +82.2% | – |
| FY2021 | Dec 31, 2021 | 197.00 | -26.4% | – |
| FY2020 | Dec 31, 2020 | 267.80 | +26,680.0% | – |
| FY2019 | Dec 31, 2019 | 1.00 | -100.0% | – |
| FY2018 | Dec 31, 2018 | 2,018.00 | – | – |
Cite this data
StockData. (2026). Merck Mectizan Donation Program — People Reached Annually for River Blindness & LF (millions), annual FY2018–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/esg_mectizan_m
See every metric in the Merck KPI table. Data updated Oct 26, 2026.